This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to the Privacy Policy and Terms of Use. Please read our cookie notice for more information on the use of cookies on this website.
Direct-to-consumer genomics in personalized medicine aims to provide customers with precise healthcare information based on individual data. But absolute confidence in individual sample integrity, identity, and quality is crucial.
The Olivia Newton-John Cancer and Wellness Centre in Australia works to discover and develop breakthrough personalized cancer medicines and targeted therapeutics.
Scientists from Duke University Medical Center in the US and the Fraunhofer Institute for Biomedical Engineering in Germany used Brooks’ XSD-48Pro as part of an automated GCLP-compliant system for HIV research.
In an independent publication, researchers cited Brooks Life Sciences CryoPod™ Carrier as an effective tool to prevent temperature excursions when stocking and retrieving frozen biological samples.
Disaster recovery plans with multiple backup systems are essential for all professional biostorage and research facilities. And freezer type can make the difference between complete sample loss and maintaining biomaterial integrity.
Storage and distribution of cell therapy products needs to be impeccably organized to positively impact patient health, with cold chain-of-custody guaranteed at all stages via automated workflows.
Modern biomedical research relies on a variety of quality biospecimens annotated with precise and detailed metadata. Consequently, biorepositories must secure excellence in all operations and convey this information to their customers.
For over a decade, institutes have recognized that sample quality affects laboratory test results. This is especially critical in the fast-growing field of precision medicine.
